{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:58:43Z","timestamp":1777658323996,"version":"3.51.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T00:00:00Z","timestamp":1492473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SoMoPro II Programme, People Programme (Marie Curie Action)","award":["3SGA5789"],"award-info":[{"award-number":["3SGA5789"]}]},{"name":"Ministry of Education, Youth and Sports of the Czech Republic","award":["CEITEC 2020 (LQ1601)"],"award-info":[{"award-number":["CEITEC 2020 (LQ1601)"]}]},{"name":"Ministry of Education, Youth and Sports of the Czech Republic","award":["MUNI\/A\/1063\/2016"],"award-info":[{"award-number":["MUNI\/A\/1063\/2016"]}]},{"name":"Faculty of Medicine MU","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12640-017-9718-9","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T05:16:15Z","timestamp":1492492575000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia"],"prefix":"10.1007","volume":"32","author":[{"given":"Jana","family":"Ruda-Kucerova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Babinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Micale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"key":"9718_CR1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.22501","volume":"33","author":"CG Abdallah","year":"2016","unstructured":"Abdallah CG, Adams TG, Kelmendi B et al (2016) Ketamine\u2019s mechanism of action: a path to rapid-acting antidepressants. Depress Anxiety 33:689\u2013697","journal-title":"Depress Anxiety"},{"key":"9718_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-013-3153-2","volume":"230","author":"L Akinfiresoye","year":"2013","unstructured":"Akinfiresoye L, Tizabi Y (2013) Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Psychopharmacol Berl 230:291\u2013298","journal-title":"Psychopharmacol Berl"},{"key":"9718_CR3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fphar.2014.00044","volume":"5","author":"P Amchova","year":"2014","unstructured":"Amchova P, Kucerova J, Giugliano V et al (2014) Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms. Front Pharmacol 5:44","journal-title":"Front Pharmacol"},{"key":"9718_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.euroneuro.2007.03.002","volume":"17","author":"F Angelucci","year":"2007","unstructured":"Angelucci F, Gruber SHM, El Khoury A et al (2007) Chronic amphetamine treatment reduces NGF and BDNF in the rat brain. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 17:756\u2013762. doi: 10.1016\/j.euroneuro.2007.03.002","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"9718_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91\u201395","journal-title":"Nature"},{"key":"9718_CR6","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000106","author":"Z Babinska","year":"2017","unstructured":"Babinska Z, Ruda-Kucerova J (2017) Differential characteristics of ketamine addiction in the olfactory bulbectomy model of depression in rats. Exp Clin Psychopharmacol in press. doi: 10.1037\/pha0000106","journal-title":"Exp Clin Psychopharmacol in press"},{"key":"9718_CR7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.neuropharm.2008.03.011","volume":"54","author":"SA Berg","year":"2008","unstructured":"Berg SA, Chambers RA (2008) Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia. Neuropharmacology 54:1201\u20131207","journal-title":"Neuropharmacology"},{"key":"9718_CR8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bbr.2010.12.017","volume":"218","author":"SA Berg","year":"2011","unstructured":"Berg SA, Czachowski CL, Chambers RA (2011) Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia. Behav Brain Res 218:346\u2013349","journal-title":"Behav Brain Res"},{"key":"9718_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bjorkholm","year":"2016","unstructured":"Bjorkholm C, Monteggia LM (2016) BDNF\u2014a key transducer of antidepressant effects. Neuropharmacology 102:72\u201379","journal-title":"Neuropharmacology"},{"key":"9718_CR10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0897190014525754","volume":"27","author":"G Bokor","year":"2014","unstructured":"Bokor G, Anderson PD (2014) Ketamine: an update on its abuse. J Pharm Pr 27:582\u2013586","journal-title":"J Pharm Pr"},{"key":"9718_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-008-1195-7","volume":"200","author":"AM Brady","year":"2008","unstructured":"Brady AM, McCallum SE, Glick SD, O\u2019Donnell P (2008) Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia. Psychopharmacol Berl 200:205\u2013215","journal-title":"Psychopharmacol Berl"},{"key":"9718_CR12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0893-133X(02)00365-2","volume":"27","author":"RA Chambers","year":"2002","unstructured":"Chambers RA, Self DW (2002) Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia. Neuropsychopharmacology 27:889\u2013905","journal-title":"Neuropsychopharmacology"},{"key":"9718_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","volume":"50","author":"RA Chambers","year":"2001","unstructured":"Chambers RA, Krystal JH, Self DW (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50:71\u201383","journal-title":"Biol Psychiatry"},{"key":"9718_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.01.022","author":"C D\u2019Addario","year":"2017","unstructured":"D\u2019Addario C, Micale V, Di Bartolomeo M et al (2017) A preliminary study of endocannabinoid system regulation in psychosis: distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia. Schizophr Res. doi: 10.1016\/j.schres.2017.01.022","journal-title":"Schizophr Res"},{"key":"9718_CR15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0925-4927(98)00016-X","volume":"82","author":"A Dahchour","year":"1998","unstructured":"Dahchour A, De Witte P, Bolo N et al (1998) Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82:107\u2013114","journal-title":"Psychiatry Res"},{"key":"9718_CR16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2013.12.019","volume":"136","author":"E Dakwar","year":"2014","unstructured":"Dakwar E, Anerella C, Hart CL et al (2014a) Therapeutic infusions of ketamine: do the psychoactive effects matter? Drug Alcohol Depend 136:153\u2013157","journal-title":"Drug Alcohol Depend"},{"key":"9718_CR17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopsych.2013.08.009","volume":"76","author":"E Dakwar","year":"2014","unstructured":"Dakwar E, Levin F, Foltin RW et al (2014b) The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers. Biol Psychiatry 76:40\u201346","journal-title":"Biol Psychiatry"},{"key":"9718_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(94)01440-S","volume":"674","author":"M Davidson","year":"1995","unstructured":"Davidson M, Shanley B, Wilce P (1995) Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study. Brain Res 674:91\u201396","journal-title":"Brain Res"},{"key":"9718_CR19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0269881115573809","volume":"29","author":"KS El Iskandrani","year":"2015","unstructured":"El Iskandrani KS, Oosterhof CA, El Mansari M, Blier P (2015) Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: an in vivo electrophysiological study on monoaminergic and glutamatergic neurons. J Psychopharmacol 29:792\u2013801","journal-title":"J Psychopharmacol"},{"key":"9718_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(92)91460-V","volume":"595","author":"GM Farfel","year":"1992","unstructured":"Farfel GM, Vosmer GL, Seiden LS (1992) The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Brain Res 595:121\u2013127","journal-title":"Brain Res"},{"key":"9718_CR21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pbb.2009.05.010","volume":"93","author":"RE Featherstone","year":"2009","unstructured":"Featherstone RE, Burton CL, Coppa-Hopman R et al (2009) Gestational treatment with methylazoxymethanol (MAM) that disrupts hippocampal-dependent memory does not alter behavioural response to cocaine. Pharmacol Biochem Behav 93:382\u2013390","journal-title":"Pharmacol Biochem Behav"},{"key":"9718_CR22","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/sj.npp.1300516","volume":"29","author":"P Flagstad","year":"2004","unstructured":"Flagstad P, Mork A, Glenthoj BY et al (2004) Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsychopharmacology 29:2052\u20132064","journal-title":"Neuropsychopharmacology"},{"key":"9718_CR23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/npp.2015.233","volume":"41","author":"K Fukumoto","year":"2016","unstructured":"Fukumoto K, Iijima M, Chaki S (2016) The antidepressant effects of an mGlu2\/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN. Neuropsychopharmacology 41:1046\u20131056","journal-title":"Neuropsychopharmacology"},{"key":"9718_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2015.04.023","volume":"97","author":"JJ Fuller","year":"2016","unstructured":"Fuller JJ, Murray RC, Horner KA (2016) D-amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in Sprague-Dawley rats are reversed by treatment with ketamine. Neuropharmacology 97:7\u201317","journal-title":"Neuropharmacology"},{"key":"9718_CR25","first-page":"511","volume":"95","author":"JW Gibb","year":"1989","unstructured":"Gibb JW, Johnson M, Hanson GR (1989) MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity. NIDA Res Monogr 95:511","journal-title":"NIDA Res Monogr"},{"key":"9718_CR26","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.euroneuro.2016.10.002","volume":"26","author":"BS Go","year":"2016","unstructured":"Go BS, Barry SM, McGinty JF (2016) Glutamatergic neurotransmission in the prefrontal cortex mediates the suppressive effect of intra-prelimbic cortical infusion of BDNF on cocaine-seeking. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 26:1989\u20131999. doi: 10.1016\/j.euroneuro.2016.10.002","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"9718_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11481-011-9288-1","volume":"7","author":"KM Grant","year":"2012","unstructured":"Grant KM, LeVan TD, Wells SM et al (2012) Methamphetamine-associated psychosis. J NeuroImmune Pharmacol 7:113\u2013139","journal-title":"J NeuroImmune Pharmacol"},{"key":"9718_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.alcohol.2016.06.004","volume":"54","author":"A Heberlein","year":"2016","unstructured":"Heberlein A, Lenz B, Opfermann B et al (2016) Association of testosterone and BDNF serum levels with craving during alcohol withdrawal. Alcohol Fayettev N 54:67\u201372. doi: 10.1016\/j.alcohol.2016.06.004","journal-title":"Alcohol Fayettev N"},{"key":"9718_CR29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/nyas.12547","volume":"1338","author":"W Hu","year":"2015","unstructured":"Hu W, MacDonald ML, Elswick DE, Sweet RA (2015) The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann N Acad Sci 1338:38\u201357","journal-title":"Ann N Acad Sci"},{"key":"9718_CR30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1254\/jjp.69.83","volume":"69","author":"I Ida","year":"1995","unstructured":"Ida I, Asami T, Kuribara H (1995) Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. Jpn J Pharmacol 69:83\u201390","journal-title":"Jpn J Pharmacol"},{"key":"9718_CR31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/adb.12146","volume":"20","author":"J Jeanblanc","year":"2014","unstructured":"Jeanblanc J, Balguerie K, Coune F et al (2014) Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia. Addict Biol 20:490\u2013499","journal-title":"Addict Biol"},{"key":"9718_CR32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.1992.tb27373.x","volume":"668","author":"M Johnson","year":"1992","unstructured":"Johnson M, Bush LG, Midgley L et al (1992) MK-801 blocks the changes in neurotensin concentrations induced by methamphetamine, 3,4-methylenedioxymethamphetamine, cocaine, and GBR 12909. Ann N Y Acad Sci 668:350\u2013352","journal-title":"Ann N Y Acad Sci"},{"key":"9718_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0269881105051542","volume":"19","author":"A Kalyoncu","year":"2005","unstructured":"Kalyoncu A, Mirsal H, Pektas O et al (2005) Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect? J Psychopharmacol 19:301\u2013305","journal-title":"J Psychopharmacol"},{"key":"9718_CR34","first-page":"32423","volume":"S0006-3223","author":"G Kaneko","year":"2016","unstructured":"Kaneko G, Sanganahalli BG, Groman SM et al (2016) Hypofrontality and posterior hyperactivity in early schizophrenia: imaging and behavior in a preclinical model. Biol Psychiatry S0006-3223:32423\u201332424","journal-title":"Biol Psychiatry"},{"key":"9718_CR35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-012-2882-y","volume":"226","author":"RM Karlsson","year":"2013","unstructured":"Karlsson RM, Kircher DM, Shaham Y, O\u2019Donnell P (2013) Exaggerated cue-induced reinstatement of cocaine seeking but not incubation of cocaine craving in a developmental rat model of schizophrenia. Psychopharmacol Berl 226:45\u201351","journal-title":"Psychopharmacol Berl"},{"key":"9718_CR36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/15504263.2013.867199","volume":"10","author":"AM Kern","year":"2014","unstructured":"Kern AM, Akerman SC, Nordstrom BR (2014) Opiate dependence in schizophrenia: case presentation and literature review. J Dual Diagn 10:52\u201357","journal-title":"J Dual Diagn"},{"key":"9718_CR37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.psychres.2014.12.006","volume":"225","author":"B Kerner","year":"2015","unstructured":"Kerner B (2015) Comorbid substance use disorders in schizophrenia: a latent class approach. Psychiatry Res 225:395\u2013401","journal-title":"Psychiatry Res"},{"key":"9718_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0361-9230(97)00093-2","volume":"44","author":"HS Kim","year":"1997","unstructured":"Kim HS, Jang CG (1997) MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice. Brain Res Bull 44:221\u2013227","journal-title":"Brain Res Bull"},{"key":"9718_CR39","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/nbm.1681","volume":"24","author":"SY Kim","year":"2011","unstructured":"Kim SY, Lee H, Kim HJ et al (2011) In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: potential relevance to schizophrenia. NMR Biomed 24:1235\u20131242","journal-title":"NMR Biomed"},{"key":"9718_CR40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00213-006-0353-z","volume":"186","author":"O Kitamura","year":"2006","unstructured":"Kitamura O, Wee S, Specio SE et al (2006) Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacol Berl 186:48\u201353","journal-title":"Psychopharmacol Berl"},{"key":"9718_CR41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbr.2014.05.065","volume":"271","author":"H Koike","year":"2014","unstructured":"Koike H, Chaki S (2014) Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats. Behav Brain Res 271:111\u2013115","journal-title":"Behav Brain Res"},{"key":"9718_CR42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760\u2013773","journal-title":"Lancet Psychiatry"},{"key":"9718_CR43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0447.2009.01385.x","volume":"120","author":"J Koskinen","year":"2009","unstructured":"Koskinen J, Lohonen J, Koponen H et al (2009) Prevalence of alcohol use disorders in schizophrenia\u2014a systematic review and meta-analysis. Acta Psychiatr Scand 120:85\u201396","journal-title":"Acta Psychiatr Scand"},{"key":"9718_CR44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0740-5472(02)00275-1","volume":"23","author":"E Krupitsky","year":"2002","unstructured":"Krupitsky E, Burakov A, Romanova T et al (2002) Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up. J Subst Abus Treat 23:273\u2013283","journal-title":"J Subst Abus Treat"},{"key":"9718_CR45","first-page":"663","volume":"30","author":"J Kucerova","year":"2009","unstructured":"Kucerova J, Vrskova D, Sulcova A (2009) Impact of repeated methamphetamine pretreatment on intravenous self-administration of the drug in males and estrogenized or non-estrogenized ovariectomized female rats. Neuroendocrinol Lett 30:663\u2013670","journal-title":"Neuroendocrinol Lett"},{"key":"9718_CR46","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1017\/S1461145711001684","volume":"15","author":"J Kucerova","year":"2012","unstructured":"Kucerova J, Pistovcakova J, Vrskova D et al (2012) The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression. Int J Neuropsychopharmacol 15:1503\u20131511. doi: 10.1017\/S1461145711001684","journal-title":"Int J Neuropsychopharmacol"},{"key":"9718_CR47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1574889809666140307115532","volume":"9","author":"J Kucerova","year":"2014","unstructured":"Kucerova J, Tabiova K, Drago F, Micale V (2014) Therapeutic potential of cannabinoids in schizophrenia. Recent Pat CNS Drug Discov 9:13\u201325","journal-title":"Recent Pat CNS Drug Discov"},{"key":"9718_CR48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","volume":"25","author":"AC Lahti","year":"2001","unstructured":"Lahti AC, Weiler MA, Tamara Michaelidis BA et al (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455\u2013467","journal-title":"Neuropsychopharmacology"},{"key":"9718_CR49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2014.02.028","volume":"730","author":"L Landa","year":"2014","unstructured":"Landa L, Machalova A, Sulcova A (2014) Implication of NMDA receptors in behavioural sensitization to psychostimulants: a short review. Eur J Pharmacol 730:77\u201381","journal-title":"Eur J Pharmacol"},{"key":"9718_CR50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0091-3057(93)90306-E","volume":"44","author":"RT Layer","year":"1993","unstructured":"Layer RT, Kaddis FG, Wallace LJ (1993) The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol Biochem Behav 44:245\u2013247","journal-title":"Pharmacol Biochem Behav"},{"key":"9718_CR51","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/0269881110387839","volume":"25","author":"G Le Pen","year":"2011","unstructured":"Le Pen G, Jay TM, Krebs M-O (2011) Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol. J Psychopharmacol Oxf Engl 25:822\u2013835. doi: 10.1177\/0269881110387839","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"9718_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw107","author":"BH Lee","year":"2016","unstructured":"Lee BH, Park TY, Lin E et al (2016) Altered acoustic startle reflex, prepulse inhibition, and peripheral brain-derived neurotrophic factor in morphine self-administered rats. Int J Neuropsychopharmacol. doi: 10.1093\/ijnp\/pyw107","journal-title":"Int J Neuropsychopharmacol"},{"key":"9718_CR53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-007-0719-x","volume":"192","author":"I Lena","year":"2007","unstructured":"Lena I, Chessel A, Le Pen G et al (2007) Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacol Berl 192:373\u2013383","journal-title":"Psychopharmacol Berl"},{"key":"9718_CR54","doi-asserted-by":"crossref","first-page":"pyu033","DOI":"10.1093\/ijnp\/pyu033","volume":"18","author":"AE Lepack","year":"2014","unstructured":"Lepack AE, Fuchikami M, Dwyer JM et al (2014) BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol 18:pyu033","journal-title":"Int J Neuropsychopharmacol"},{"key":"9718_CR55","doi-asserted-by":"crossref","unstructured":"Li X, Li S, Zheng W, Pan J, Huang K, Chen R, Pan T, Liao G, Chen Z, Zhou D, Shen W, Zhou W, Liu Y (2016) Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity. Sci Rep 5:11611","DOI":"10.1038\/srep11611"},{"key":"9718_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0893-133X(00)00137-8","volume":"23","author":"BK Lipska","year":"2000","unstructured":"Lipska BK, Weinberger DR (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 23:223\u2013239. doi: 10.1016\/S0893-133X(00)00137-8","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"9718_CR57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001756-200401190-00039","volume":"15","author":"X Liu","year":"2004","unstructured":"Liu X, Lee JG, Yee SK et al (2004) Endotoxin exposure in utero increases ethanol consumption in adult male offspring. Neuroreport 15:203\u2013206","journal-title":"Neuroreport"},{"key":"9718_CR58","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","volume":"27","author":"DJ Lodge","year":"2007","unstructured":"Lodge DJ, Grace AA (2007) Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci 27:11424\u201311430","journal-title":"J Neurosci"},{"key":"9718_CR59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2009.01.031","volume":"204","author":"DJ Lodge","year":"2009","unstructured":"Lodge DJ, Grace AA (2009) Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia. Behav Brain Res 204:306\u2013312","journal-title":"Behav Brain Res"},{"key":"9718_CR60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1461145711000113","volume":"15","author":"DJ Lodge","year":"2012","unstructured":"Lodge DJ, Grace AA (2012) Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia. Int J Neuropsychopharmacol 15:69\u201376","journal-title":"Int J Neuropsychopharmacol"},{"key":"9718_CR61","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0006-8993(90)91362-K","volume":"533","author":"MT Lowy","year":"1990","unstructured":"Lowy MT (1990) MK-801 antagonizes methamphetamine-induced decreases in hippocampal and striatal corticosteroid receptors. Brain Res 533:348\u2013352","journal-title":"Brain Res"},{"key":"9718_CR62","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.psc.2009.09.002","volume":"32","author":"J Lybrand","year":"2009","unstructured":"Lybrand J, Caroff S (2009) Management of schizophrenia with substance use disorders. Psychiatr Clin North Am 32:821\u2013833","journal-title":"Psychiatr Clin North Am"},{"key":"9718_CR63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pnpbp.2013.07.010","volume":"52","author":"KM Mackowick","year":"2014","unstructured":"Mackowick KM, Barr MS, Wing VC et al (2014) Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. Prog Neuro-Psychopharmacol Biol Psychiatry 52:79\u201385","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"9718_CR64","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0028-3908(00)00199-4","volume":"40","author":"MM Marcus","year":"2001","unstructured":"Marcus MM, Mathe JM, Nomikos GG, Svensson TH (2001) Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Neuropharmacology 40:482\u2013490","journal-title":"Neuropharmacology"},{"key":"9718_CR65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1213\/00000539-200301000-00030","volume":"96","author":"M Masuzawa","year":"2003","unstructured":"Masuzawa M, Nakao S, Miyamoto E et al (2003) Pentobarbital inhibits ketamine-induced dopamine release in the rat nucleus accumbens: a microdialysis study. Anesth Analg 96:148\u2013152","journal-title":"Anesth Analg"},{"key":"9718_CR66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/(SICI)1097-4547(19980301)51:5<583::AID-JNR5>3.0.CO;2-B","volume":"51","author":"JM Mathe","year":"1998","unstructured":"Mathe JM, Nomikos GG, Schilstrom B, Svensson TH (1998) Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J Neurosci Res 51:583\u2013592","journal-title":"J Neurosci Res"},{"key":"9718_CR67","first-page":"CD004837","volume":"10","author":"BC McLoughlin","year":"2014","unstructured":"McLoughlin BC, Pushpa-Rajah JA, Gillies D et al (2014) Cannabis and schizophrenia. Cochrane Database Syst Rev 10:CD004837","journal-title":"Cochrane Database Syst Rev"},{"key":"9718_CR68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.schres.2014.03.002","volume":"155","author":"RI Mesholam-Gately","year":"2014","unstructured":"Mesholam-Gately RI, Gibson LE, Seidman LJ, Green AI (2014) Schizophrenia and co-occurring substance use disorder: reward, olfaction and clozapine. Schizophr Res 155:45\u201351","journal-title":"Schizophr Res"},{"key":"9718_CR69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00441-013-1692-9","volume":"354","author":"V Micale","year":"2013","unstructured":"Micale V, Kucerova J, Sulcova A (2013) Leading compounds for the validation of animal models of psychopathology. Cell Tissue Res 354:309\u2013330","journal-title":"Cell Tissue Res"},{"key":"9718_CR70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","volume":"100","author":"OH Miller","year":"2016","unstructured":"Miller OH, Moran JT, Hall BJ (2016) Two cellular hypotheses explaining the initiation of ketamine\u2019s antidepressant actions: direct inhibition and disinhibition. Neuropharmacology 100:17\u201326","journal-title":"Neuropharmacology"},{"key":"9718_CR71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(92)90642-K","volume":"136","author":"A Muraki","year":"1992","unstructured":"Muraki A, Koyama T, Nakayama M et al (1992) MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum. Neurosci Lett 136:39\u201342","journal-title":"Neurosci Lett"},{"key":"9718_CR72","doi-asserted-by":"crossref","unstructured":"Mutti A, Aroni S, Fadda P, Padovani L, Mancini L, Collu R, Muntoni AL, Fattore L, Chiamulera C (2016) The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission. Psychopharmacology (Berl) 233(12):2241-225","DOI":"10.1007\/s00213-016-4275-0"},{"key":"9718_CR73","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.pbb.2011.04.015","volume":"100","author":"MF Olive","year":"2012","unstructured":"Olive MF, Cleva RM, Kalivas PW, Malcolm RJ (2012) Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav 100:801\u2013810","journal-title":"Pharmacol Biochem Behav"},{"key":"9718_CR74","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.neuropharm.2011.04.006","volume":"62","author":"KG Phillips","year":"2012","unstructured":"Phillips KG, Cotel MC, McCarthy AP et al (2012) Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia. Neuropharmacology 62:1359\u20131370","journal-title":"Neuropharmacology"},{"key":"9718_CR75","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neuropharm.2014.04.002","volume":"87","author":"KA Phillips","year":"2014","unstructured":"Phillips KA, Epstein DH, Preston KL (2014) Psychostimulant addiction treatment. Neuropharmacology 87:150\u2013160","journal-title":"Neuropharmacology"},{"key":"9718_CR76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2007-993212","volume":"41","author":"J Pistovcakova","year":"2008","unstructured":"Pistovcakova J, Dostalek M, Sulcova A, Jezova D (2008) Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression. Pharmacopsychiatry 41:54\u201359","journal-title":"Pharmacopsychiatry"},{"key":"9718_CR77","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","volume":"264","author":"DA Regier","year":"1990","unstructured":"Regier DA, Farmer ME, Rae DS et al (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 264:2511\u20132518","journal-title":"JAMA"},{"key":"9718_CR78","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1038\/tp.2015.157","volume":"5","author":"Q Ren","year":"2015","unstructured":"Ren Q, Ma M, Yang C et al (2015) BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms. Transl Psychiatry 5:e666","journal-title":"Transl Psychiatry"},{"key":"9718_CR79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00213-012-2646-8","volume":"222","author":"NM Richtand","year":"2012","unstructured":"Richtand NM, Ahlbrand R, Horn PS et al (2012) Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat. Psychopharmacol Berl 222:313\u2013324","journal-title":"Psychopharmacol Berl"},{"key":"9718_CR80","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.neubiorev.2013.04.017","volume":"37","author":"DC Roberts","year":"2013","unstructured":"Roberts DC, Gabriele A, Zimmer BA (2013) Conflation of cocaine seeking and cocaine taking responses in IV self-administration experiments in rats: methodological and interpretational considerations. Neurosci Biobehav Rev 37:2026\u20132036","journal-title":"Neurosci Biobehav Rev"},{"key":"9718_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2015.00091","volume":"6","author":"J Ruda-Kucerova","year":"2015","unstructured":"Ruda-Kucerova J, Amchova P, Babinska Z et al (2015) Sex differences in the reinstatement of methamphetamine seeking after forced abstinence in Sprague-Dawley rats. Front Psychiatry 6:1\u20138","journal-title":"Front Psychiatry"},{"key":"9718_CR82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15622975.2016.1190032","volume":"18","author":"J Ruda-Kucerova","year":"2017","unstructured":"Ruda-Kucerova J, Babinska Z, Amchova P et al (2017) Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats. World J Biol Psychiatry 18:129\u2013142","journal-title":"World J Biol Psychiatry"},{"key":"9718_CR83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fnins.2015.00249","volume":"9","author":"L Scheuing","year":"2015","unstructured":"Scheuing L, Chiu CT, Liao HM, Chuang DM (2015) Antidepressant mechanism of ketamine: perspective from preclinical studies. Front Neurosci 9:249","journal-title":"Front Neurosci"},{"key":"9718_CR84","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0024-3205(00)00639-1","volume":"67","author":"T Suzuki","year":"2000","unstructured":"Suzuki T, Kato H, Aoki T et al (2000) Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. Life Sci 67:383\u2013389","journal-title":"Life Sci"},{"key":"9718_CR85","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0304-3940(98)00023-8","volume":"242","author":"TM Tzschentke","year":"1998","unstructured":"Tzschentke TM, Schmidt WJ (1998) Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole. Neurosci Lett 242:114\u2013116","journal-title":"Neurosci Lett"},{"key":"9718_CR86","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/15622970802176487","volume":"11","author":"D Wedekind","year":"2010","unstructured":"Wedekind D, Jacobs S, Karg I et al (2010) Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with L- and D,L-methadone. World J Biol Psychiatry 11:390\u2013399","journal-title":"World J Biol Psychiatry"},{"key":"9718_CR87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0006-8993(91)90462-5","volume":"549","author":"FB Weihmuller","year":"1991","unstructured":"Weihmuller FB, O\u2019Dell SJ, Cole BN, Marshall JF (1991) MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res 549:230\u2013235","journal-title":"Brain Res"},{"key":"9718_CR88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2011.06261.x","volume":"1248","author":"VC Wing","year":"2012","unstructured":"Wing VC, Wass CE, Soh DW, George TP (2012) A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann N Acad Sci 1248:89\u2013106","journal-title":"Ann N Acad Sci"},{"key":"9718_CR89","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000127492","volume":"15","author":"DD Xu","year":"2006","unstructured":"Xu DD, Mo ZX, Yung KK et al (2006) Individual and combined effects of methamphetamine and ketamine on conditioned place preference and NR1 receptor phosphorylation in rats. Neurosignals 15:322\u2013331","journal-title":"Neurosignals"},{"key":"9718_CR90","first-page":"1","volume":"19","author":"Y Xu","year":"2016","unstructured":"Xu Y, Hackett M, Carter G et al (2016) Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis. Int J Neuropsychopharmacol 19:1\u201315","journal-title":"Int J Neuropsychopharmacol"},{"key":"9718_CR91","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/7854_2010_62","volume":"4","author":"JW Young","year":"2010","unstructured":"Young JW, Zhou X, Geyer MA (2010) Animal models of schizophrenia. Curr Top Behav Neurosci 4:391\u2013433","journal-title":"Curr Top Behav Neurosci"},{"key":"9718_CR92","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","volume":"232","author":"JC Zhang","year":"2015","unstructured":"Zhang JC, Yao W, Dong C et al (2015) Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Psychopharmacol Berl 232:4325\u20134335","journal-title":"Psychopharmacol Berl"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-017-9718-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-017-9718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T15:25:27Z","timestamp":1658935527000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-017-9718-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["9718"],"URL":"https:\/\/doi.org\/10.1007\/s12640-017-9718-9","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]}}}